Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 79
  • Journal CiteScore: 29.12
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +447482874092

Short Report - (2021) Volume 0, Issue 0

A short report on Focal autoimmune Pancreatitis

Narender Singh

Center for Bio-Technology, Institute of Science & Technology, JNTU University, India

Corresponding Author:
Narender Singh
Center for Bio-Technology, Institute of Science & Technology, JNTU University, India
Tel: 9985306454
E-mail: [email protected]

Received Date: February 20th, 2021; Accepted Date: February 24th, 2021

Visit for more related articles at Journal of the Pancreas

Autoimmune pancreatitis (AIP) is a chronic fibroinflammatory autoimmune mediated disease of the pancreas. It is a rare, but increasingly recognized disease. Clinically, obstructive painless jaundice and upper abdominal pain are the main presentations.

Focusing on focal AIP, describing the available tests to better diagnose the disease ruling out pancreatic cancer and giving a possible effective diagnostic approach.

Focal AIP (f-AIP) is characterized by a segmental involvement of the pancreatic parenchyma and it is often radiologically represented by a pancreatic mass. In these cases, the diagnosis can be very challenging, as the main diagnostic problem is that it may be easily confused with pancreatic cancer. Then, being the f-AIP a benign condition dramatically responsive to steroid therapy, it is mandatory to rule out the cancer. However, the prevalence of pancreatic cancer in the general population is much higher than that of AIP; it is the fourth leading cause of cancer related fatalities in Western countries and early treatment is crucial for achieving cure.